ASPI
ASP Isotopes Inc. Common StockNASDAQBasic Materials$4.29+4.38%ClosedMarket Cap: $400.7M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
5.13
P/S
47.80
EV/EBITDA
-3.77
DCF Value
$0.40
FCF Yield
-8.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
23.0%
Operating Margin
-507.4%
Net Margin
-1259.2%
ROE
-222.6%
ROA
-48.5%
ROIC
-20.2%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $4.9M | $-12.9M | $-0.15 |
| Q2 2025 | $1.2M | $-75.1M | $-1.03 |
| Q1 2025 | $1.1M | $-8.4M | $-0.12 |
| Q4 2024 | $1.2M | $-9.2M | $-0.16 |
Analyst Ratings
View AllCanaccord GenuityBuy
2025-11-24Canaccord GenuityBuy
2025-09-17Canaccord GenuityBuy
2025-05-21Trading Activity
Insider Trades
View AllAinscow Robertofficer: COO
SellFri Mar 06
Mann Paul Elliotofficer: Executive Chairman
SellMon Mar 02
Kiessling Heatherofficer: Chief Financial Officer
SellMon Dec 29
Wider Todddirector
SellMon Dec 22
Ryan Robert John Andrewdirector
SellMon Dec 22
Company Info
Sector
Basic Materials
Industry
—
Country
US
Exchange
NASDAQ
Beta
3.61
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.